Zegeng Chen

5PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 10, 2026
Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trial.

Huangming Hong, Zegeng Chen, Jie Cui

|Feb 20, 2024
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma.

Zegeng Chen, He Huang, Huageng Huang

|Nov 24, 2023
Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group.

Huawei Weng, Prem Raj Shrestha, Huangming Hong

|Jan 09, 2023
A study on the prevention of hemorrhage and perforation in patients with primary gastric diffuse large-B cell lymphoma during treatment with immunochemotherapy.

Limei Zhang, He Huang, Zhao Wang

|Apr 30, 2022
A novel prognostic nomogram for patients with extragastric mucosa-associated lymphoid tissue lymphoma: A multicenter study.

Xiaoqian Li, Huangming Hong, He Huang

Pageof 1

Frequent Collaborators

2 joint publications

Huangming Hong

1 joint publications

Xiaoqian Li

1 joint publications

Limei Zhang

1 joint publications

Quanguang Ren